Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionExchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares IssuedShort-Term Debt repayments
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Incannex Healthcare (IXHL) Non-cash Items (2023 - 2025)

Incannex Healthcare's Non-cash Items history spans 3 years, with the latest figure at $57000.0 for Q1 2025.

  • On a quarterly basis, Non-cash Items fell 42.42% to $57000.0 in Q1 2025 year-over-year; TTM through Mar 2025 was $57000.0, a 42.42% decrease, with the full-year FY2024 number at $114.0 million, up 76410.07% from a year prior.
  • Non-cash Items hit $57000.0 in Q1 2025 for Incannex Healthcare, down from $56.7 million in the prior quarter.
  • Over the last five years, Non-cash Items for IXHL hit a ceiling of $114.0 million in Q2 2024 and a floor of $57000.0 in Q1 2025.
  • Historically, Non-cash Items has averaged $32.1 million across 3 years, with a median of $426500.0 in 2023.
  • Biggest five-year swings in Non-cash Items: surged 76410.07% in 2024 and later crashed 42.42% in 2025.
  • Tracing IXHL's Non-cash Items over 3 years: stood at $411000.0 in 2023, then surged by 13702.19% to $56.7 million in 2024, then plummeted by 99.9% to $57000.0 in 2025.
  • Business Quant data shows Non-cash Items for IXHL at $57000.0 in Q1 2025, $56.7 million in Q4 2024, and $85.1 million in Q3 2024.